- Report
- April 2024
- 1800 Pages
Global
From €3833EUR$3,995USD£3,315GBP
- Report
- March 2024
- 192 Pages
Global
From €3237EUR$3,374USD£2,799GBP
€3597EUR$3,749USD£3,111GBP
- Report
- March 2024
- 196 Pages
Global
From €3237EUR$3,374USD£2,799GBP
€3597EUR$3,749USD£3,111GBP
- Report
- September 2023
- 249 Pages
Global
From €4728EUR$5,100USD£3,950GBP
- Report
- June 2023
- 186 Pages
Global
From €5277EUR$5,500USD£4,563GBP
- Report
- February 2024
- 175 Pages
Global
From €4797EUR$5,000USD£4,148GBP
- Report
- January 2024
- 200 Pages
Global
From €4797EUR$5,000USD£4,148GBP
- Report
- November 2023
- 178 Pages
Global
From €4701EUR$4,900USD£4,065GBP
- Report
- November 2023
- 630 Pages
Global
From €9115EUR$9,500USD£7,882GBP
- Report
- January 2024
- 215 Pages
Global
From €7628EUR$7,950USD£6,596GBP
- Report
- November 2023
- 178 Pages
Global
From €4701EUR$4,900USD£4,065GBP
- Report
- January 2024
- 200 Pages
Global
From €3982EUR$4,150USD£3,443GBP
- Report
- December 2023
- 140 Pages
Global
From €4270EUR$4,450USD£3,692GBP
- Newsletter
- May 2024
- 88 Pages
Global
€1265EUR$1,318USD£1,094GBP
- Report
- January 2024
- 168 Pages
Global
€4793EUR$4,995USD£4,144GBP
- Report
- December 2023
- 212 Pages
Global
€4793EUR$4,995USD£4,144GBP
- Report
- December 2023
Global
From €7196EUR$7,500USD£6,223GBP
- Report
- August 2022
- 214 Pages
Global
From €4605EUR$4,799USD£3,982GBP
- Report
- January 2023
- 315 Pages
Global
From €4605EUR$4,799USD£3,982GBP
- Report
- June 2022
- 257 Pages
Global
From €5037EUR$5,250USD£4,356GBP
Melanoma is a type of cancer that affects the skin and is the most serious form of skin cancer. It is caused by the uncontrolled growth of pigment-producing cells, known as melanocytes. Melanoma is the fifth most common cancer in the United States, with an estimated 87,110 new cases in 2020. It is also the leading cause of death from skin disease.
The melanoma market within the oncology space is a rapidly growing segment, driven by the increasing prevalence of the disease and the development of new treatments. The market is expected to be driven by the increasing adoption of targeted therapies, immunotherapies, and combination therapies. Additionally, the increasing focus on personalized medicine and the development of novel drug delivery systems are expected to drive the market.
Some of the key players in the melanoma market include Bristol-Myers Squibb, Merck & Co., Novartis, Roche, Pfizer, and Eli Lilly. Show Less Read more